Zhang Bo, Lu Cheng, Bai Ming, He Xiaojuan, Tan Yong, Bian Yanqin, Xiao Cheng, Zhang Ge, Lu Aiping, Li Shao
MOE Key Laboratory of Bioinformatics and Bioinformatics Division, TNLIST/Department of Automation, Tsinghua University, Beijing, 100084, China; Tianjin International Joint Academy of Biotechnology & Medicine, Tianjin, 300457, China.
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, 100700, China; Institute for Advancing Translational Medicine in Bone & Joint Diseases, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong Special Administrative Region, 00852, China.
J Ethnopharmacol. 2015 Dec 4;175:638-47. doi: 10.1016/j.jep.2015.09.034. Epub 2015 Oct 3.
Tetramethylpyrazine (TMP) is one of the active constituents extracted from a frequently used herb, Ligusticum wallichii Franchat (Chuan-Xiong in Chinese), in traditional Chinese medicine. TMP can exert multiple pharmacological actions such as anti-inflammatory, anti-oxidative damage, anti-platelet and neuroprotective effects, and its applications deserve further explored.
This study aimed to determine the new role of TMP identified by a network pharmacology approach to alleviate the methotrexate (MTX)-induced oxidative injury and characterize their mechanism of combinational actions.
A network pharmacology-based screening strategy is applied for target profile prediction and pharmacological characterization of herbal compounds, which is used to guide the following in vitro and in vivo experiments. The effect of herbal compounds identified by network pharmacology approaches to reduce the toxicity of MTX was assessed by MTX-induced rat toxicity model. The potential targets of TMP in this study were evaluated using standard protocols provided by Cerep, Inc.
This strategy identified TMP from Ligusticum wallichii Franchat as a potent compound for ameliorating the oxidative organ injury of MTX. According to the predicted target profiles of TMP, a possible mechanism of the abrogation of MTX-induced toxicity is that TMP could upregulate cAMP by inhibiting phosphodiesterase (PDE) 10A2 activity. Another novel finding is that the competitive binding and antagonistic effects of TMP on adenosine receptor 2A and 2B appear to play important roles in the TMP-mediated reversal of MTX-induced hepatic injury.
TMP identified by a network pharmacology approach could ameliorate MTX-induced oxidative organ injury. This study provides important evidence for the preclinical evaluation of TMP and MTX as a novel combinatorial remedy.
川芎嗪(TMP)是从传统中药中常用草药川芎(Ligusticum wallichii Franchat)中提取的活性成分之一。川芎嗪可发挥多种药理作用,如抗炎、抗氧化损伤、抗血小板和神经保护作用,其应用值得进一步探索。
本研究旨在确定通过网络药理学方法鉴定的川芎嗪减轻甲氨蝶呤(MTX)诱导的氧化损伤的新作用,并表征其联合作用机制。
应用基于网络药理学的筛选策略对草药化合物进行靶点预测和药理表征,以指导后续的体外和体内实验。通过MTX诱导的大鼠毒性模型评估网络药理学方法鉴定的草药化合物降低MTX毒性的作用。本研究中川芎嗪的潜在靶点使用Cerep公司提供的标准方案进行评估。
该策略确定川芎中的川芎嗪是改善MTX氧化器官损伤的有效化合物。根据川芎嗪的预测靶点谱,MTX诱导毒性消除的可能机制是川芎嗪可通过抑制磷酸二酯酶(PDE)10A2活性上调cAMP。另一个新发现是,川芎嗪对腺苷受体2A和2B的竞争性结合和拮抗作用似乎在川芎嗪介导的MTX诱导肝损伤逆转中起重要作用。
通过网络药理学方法鉴定的川芎嗪可改善MTX诱导的氧化器官损伤。本研究为川芎嗪和MTX作为新型联合疗法的临床前评估提供了重要证据。